Dr. Leigh Beveridge is a physician-scientist and senior biotechnology executive specializing in hematology, oncology, and immunology. With over a decade of experience spanning academic medicine and global drug development, he has led pivotal late-stage programs that bring breakthrough therapies to patients worldwide. His career includes leadership roles at Genentech and Servier, where he directed clinical and regulatory strategies for hematologic and autoimmune conditions, including landmark therapies in complement inhibition and leukemia. A practicing physician by training, Leigh’s work is grounded in scientific rigor, patient-centered care, and ethical leadership. He is equally passionate about mentoring future leaders, serving as a Graduate Teaching Assistant at UC Davis, where he bridges medicine, management, and communication. Originally from Australia, Leigh’s approach blends analytical thinking with empathy — a reflection of his early life surrounded by teachers, innovators, and storytellers.